1 Bousser MG，Ferro JM. Cerebral venous thrombosis：

an update[J]. Lancet Neurol，2007，6：162-170.

2 Dahlback B，Carlsson M，Svensson PJ. Familial

thrombophilia due to a previously unrecognized

mechanism characterized by poor anticoagulant

response to activated protein C：prediction of a

cofactor to activated protein C[J]. Proc Natl Acad Sci

USA，1993，90：1004-1008.

3 Stephan M. Thrombophi l ia：2009 update[J ].

Cardiovascular Medicine，2009，11：114-128.

4 Or i k a z a CM，Mor el l i VM，Matos MF，e t a l .

Haplotypes of TAFI gene and the risk of cerebral

venous thrombosis--a case-control study[J]. Thromb

Res，2014，133：120-124.

5 Aaron S，Alexander M，Maya T，et al. Underlying

prothrombotic states in pregnancy associated cerebral

venous thrombosis[J]. Neurol India，2010，58：555-

559.

6 Marjot T，Yadav S，Hasan N，et al. Genes associated

with adult cerebral venous thrombosis[J]. Stroke，2011，

42：913-918.

7 Ben Salem-Berrabah O，Fekih-Mrissa N，N'Siri

B，et al. Thrombophilic polymorphisms-factor V

Leiden G1691A，prothrombin G20210A and MTHFR

C677T-in Tunisian patients with cerebral venous

thrombosis[J]. J Clin Neurosci，2012，19：1326-1327.

8 Lichy C，Dong-Si T，Reuner K，et al. Risk of cerebral

venous thrombosis and novel gene polymorphisms of

the coagulation and fibrinolytic systems[J]. J Neurol，

2006，253：316-320.

9 Kenet G，Lutkhoff LK，Albisetti M，et al. Impact

of thrombophilia on risk of arterial ischemic stroke

or cerebral sinovenous thrombosis in neonates and

children：a systematic review and meta-analysis of

observational studies[J]. Circulation，2010，121：1838-

1847.

10 Dag ZO，Isik Y，Simsek Y，et al. HELLP syndrome

and cerebral venous sinus thrombosis associated with

Factor V leiden mutation during pregnancy[J]. Case

Rep Obstet Gynecol，2014，2014：582890.

11 Ar royave JA，Quinones J. Mut at ion i n the

prothrombin gene G20210A as a cause of cerebral

venous thrombosis[J]. Case Rep Med，2012，2012：

828050.

12 Poor t SR，Rosendaal FR，Reitsma PH，et al. A

common genetic variation in the 3'-untranslated

region of the prothrombin gene is associated with

elevated plasma prothrombin levels and an increase in

venous thrombosis[J]. Blood，1996，88：3698-3703.

13 Bloem BR，van Putten MJ，van der Meer FJ，et

al. Superior sagittal sinus thrombosis in a patient

heterozygous for the novel 20210 A allele of the

prothrombin gene[J]. Thromb Haemost，1998，79：

235.

14 Ringelstein M，Jung A，Berger K，et al. Promotor

polymorphisms of plasminogen activator inhibitor-1

and other thrombophilic genotypes in cerebral venous

thrombosis：a case-control study in adults[J]. J Neurol，

2012，259：2287-2292.

15 Otrock ZK，Taher AT，Shamseddeen WA，et al.

Thrombophilic risk factors among 16 Lebanese

patients with cerebral venous and sinus thrombosis[J].

J Thromb Thrombolysis，2008，26：41-43.

16 Pat nai k MM，Moll S. Inher ited ant ithrombin

deficiency：a review[J]. Haemophilia，2008，14：

1229-1239.

17 Egeberg O. Interited antithrombin deficiency causing

thrombophilia[J]. Thromb Diath Haemorrh，1965，13：

516-530.

18 Zhang GS，Tang YM，Tang MQ，et al. Antithrombin

Cambr idge II(A384S) mutation frequency and

antithrombin activity levels in 120 of deep venous

thrombosis and 150 of cerebral infarction patients in

a single center in Southern China[J]. Blood Coagul

Fibrinolysis，2010，21：588-591.

19 Roldan V，Ordonez A，Marin F，et al. Antithrombin

Cambridge II (A384S) supports a role for antithrombin

deficiency in arterial thrombosis[J]. Thromb Haemost，

2009，101：483-486.

20 Griffin JH，Evatt B，Zimmerman TS，et al. Deficiency

of protein C in congenital thrombotic disease[J]. J

Clin Invest，1981，68：1370-1373.

21 de Kort EH，Vrancken SL，van Heijst AF，et al. Long

term subcutaneous protein C replacement in neonatal

severe protein C deficiency[J]. Pediatrics，2011，127：

e1338-1342.

22 Le Cam-Duchez V，Bagan-Triquenot A，Menard

JF，et al. Association of the protein C promoter CG

haplotype and the factor II G20210A mutation is a

risk factor for cerebral venous thrombosis[J]. Blood

Coagul Fibrinolysis，2005，16：495-500.

23 Hassan KM，Kumar D. Reversible diencephalic

dysfunction as presentation of deep cerebral venous

thrombosis due to hyperhomocysteinemia and protein

S deficiency：Documentation of a case[J]. J Neurosci

Rural Pract，2013，4：193-196.

24 Matsubara S，Satoh K，Satomi J，et al. Acquired pial

and dural arteriovenous fistulae following superior

sagittal sinus thrombosis in patients with protein S

deficiency：a report of two cases[J]. Neurol Med Chir

(Tokyo)，2014，54：245-252.

25 Eaton DL，Malloy BE，Tsai SP，et al. Isolation，

molecular cloning，and partial characterization of a

novel carboxypeptidase B from human plasma[J]. J

Biol Chem，1991，266：21833-21838.

26 Tokgoz S，Zamani AG，Durakbasi-Dursun HG，et al.

TAFI gene polymorphisms in patients with cerebral

venous thrombosis[J]. Acta Neurol Belg，2013，113：

291-297.

27 Qian K，Xu J，Wan H，et al. Impact of genetic

polymorphisms in thrombin activatable fibrinolysis

inhibitor (TAFI) on venous thrombosis disease：A

meta-analysis[J]. Gene，2015，569：173-181.

28 de Bruijne EL，Gils A，Guimaraes AH，et al. The

role of thrombin activatable fibrinolysis inhibitor

in arterial thrombosis at a young age：the ATTAC

study[J]. J Thromb Haemost，2009，7：919-927.

29 Kruthika-Vinod TP，Nagaraja D，Christopher R.

Coagulation factor VII R353Q polymorphism and the

risk of puerperal cerebral venous thrombosis[J]. J Clin

Neurosci，2012，19：190-191.

30 Zee RY，Glynn RJ，Cheng S，et al. An evaluation of

candidate genes of inflammation and thrombosis in

relation to the risk of venous thromboembolism：The

Women's Genome Health Study[J]. Circ Cardiovasc

Genet，2009，2：57-62.

31 Romisch J. Factor VII activating protease (FSAP)：a

novel protease in hemostasis[J]. Biol Chem，2002，383：

1119-1124.

32 Weisbach V，Ruppel R，Eckstein R. The Marburg I

polymorphism of factor VII-activating protease and

the risk of venous thromboembolism[J]. Thromb

Haemost，2007，97：870-872.

33 Ahmad-Nejad P，Dempfle CE，Weiss C，et al. The

G534E-polymorphism of the gene encoding the factor

VII-activating protease is a risk factor for venous

thrombosis and recurrent events[J]. Thromb Res，

2012，130：441-444.

34 Dikici S，Saritas A，Besir FH，et al. May headache

be the first sign of mutation in the MTHFR gene?[J].

World J Emerg Med，2013，4：69-72.

35 Bharatkumar VP，Nagaraja D，Ch r istopher R.

Hyperhomocysteinemia and methylenetetrahydrofolate

reductase C677T polymorphism in cerebral veno-sinus

thrombosis[J]. Clin Appl Thromb Hemost，2014，20：

78-83.

36 Yadav DD，De T，Nagaraja D，et al. Protein Z

G79A polymorphism and puerperal cerebral venous

thrombosis[J]. Clin Appl Thromb Hemost，2015，21：

768-771.

37 Le Cam-Duchez V，Bagan-Triquenot A，Barbay

V，et al. The G79A polymorphism of protein Z gene

is an independent risk factor for cerebral venous

thrombosis[J]. J Neurol，2008，255：1521-1525.

38 Passamonti SM，Biguzzi E，Cazzola M，et al. The

JAK2 V617F mutation in patients with cerebral venous

thrombosis[J]. J Thromb Haemost，2012，10：998-

1003.

39 De T，Prabhakar P，Nagaraja D，et al. Janus kinase

(JAK) 2 V617F mutation in Asian Indians with

cerebral venous thrombosis and without over t

myeloproliferative disorders [J]. J Neurol Sci，2012，

323:178-182.